Gea 3162
| Code | Size | Price |
|---|
| TAR-T27408-5mg | 5mg | £1,167.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Gea 3162 is a potent inhibitor of ADP-induced platelet aggregation in platelet rich plasma (PRP). GEA 3162 stimulates cGMP production in granulocytes, platelets, and polymorphonuclear leukocytes.
CAS:
144576-10-3
Formula:
C7H6Cl2N4O
Molecular Weight:
233.05
Purity:
0.98
SMILES:
NC1=N[NH+]([N-]O1)c1ccc(Cl)c(Cl)c1
References
1. Corell, T., et al., . Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Polish journal of pharmacology. 46(6): 553-66. PMID: 7542520
2. Karup, G., et al., . Mesoionic oxatriazole derivatives--a new group of NO-donors. Polish journal of pharmacology. 46(6): 541-52. PMID: 7620516